Innovation Spotlight: The Future of Business
7 months ago
A Safer CB1 Drug? Corbus Bets on a Comeback in the Obesity Market
A once-failed class of weight-loss drugs is back with a new design. Corbus Pharma's early data suggests it may have solved the safety puzzle.
Read full article
